Inventor · disambiguated record
Craig Johnstone
Also filed as: JOHNSTONE CRAIG
25 granted patents·20 pending applications·1,196 citations·filing 1997–2014
97Inventor score
Top patents by PatentIndex Score
45 records- 0198US6399602B1Quinazoline derivativesZENECA LTD·Filed 1998·Granted Jun 4, 2002·234 cites·20 claims
- 0298US5866572AQuinazoline derivativesZENECA LTD·Filed 1997·Granted Feb 2, 1999·333 cites·11 claims
- 0396US7524957B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2008·Granted Apr 28, 2009·31 cites·22 claims
- 0495US6897214B2Quinazoline derivativesZENECA LTD·Filed 2002·Granted May 24, 2005·39 cites·9 claims
- 0595US6673803B2Quinazoline derivatives and pharmaceutical compositions containing themZENECA LTD·Filed 2002·Granted Jan 6, 2004·68 cites·13 claims
- 0694US7745475B2Heteroaryl benzamide derivatives as GLK activatorsASTRAZENECA AB·Filed 2005·Granted Jun 29, 2010·14 cites·3 claims
- 0793US6414148B1Quinazoline derivatives and pharmaceutical compositions containing themZENECA LTD·Filed 1997·Granted Jul 2, 2002·96 cites·23 claims
- 0891US6184225B1Quinazoline derivatives as VEGF inhibitorsZENECA LTD·Filed 1997·Granted Feb 6, 2001·112 cites·18 claims
- 0990US7390908B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2002·Granted Jun 24, 2008·33 cites·19 claims
- 1087US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 1187US7098240B2CompoundsASTRAZENECA AB·Filed 2002·Granted Aug 29, 2006·33 cites·15 claims
- 1286US7358376B2Substituted Thiophene compoundsASTRAZENECA AB·Filed 2001·Granted Apr 15, 2008·22 cites·17 claims
- 1386US6897210B2Quinazoline derivatives and pharmaceutical compositions containing themZENECA PHARMA SA·Filed 2003·Granted May 24, 2005·26 cites·6 claims
- 1485US7125896B2Thiophene carboxamide compounds as inhibitors of enzyme IKK-2ASTRAZENECA AB·Filed 2002·Granted Oct 24, 2006·27 cites·12 claims
- 1583US6291455B14-anilinoquinazoline derivativesZENECA LTD·Filed 1997·Granted Sep 18, 2001·56 cites·12 claims
- 1675US9309243B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2013·Granted Apr 12, 2016·4 cites·11 claims
- 1774US9475820B2Substituted imidazo[1,2-a]pyrazines as TNF activity modulatorsUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 25, 2016·3 cites·14 claims
- 1873US7951830B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2009·Granted May 31, 2011·1 cites·11 claims
- 1972US5814630AQuinazoline compoundsZENECA LTD·Filed 1997·Granted Sep 29, 1998·33 cites·7 claims
- 2066US7572826B2Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2ASTRAZENECA AB·Filed 2004·Granted Aug 11, 2009·2 cites·16 claims
- 2162USRE42353EQuinazoline derivatives and pharmaceutical compositions containing themASTRAZENECA UK LTD·Filed 1997·Granted May 10, 2011·13 cites·23 claims
- 2260US7956084B2Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2ASTRAZENECA AB·Filed 2006·Granted Jun 7, 2011·0 cites·2 claims
- 2360US2010029754A1Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2459US2005239777A1Quinazoline derivatives and pharmaceutical compositions containing themTHOMAS ANDREW P·Filed 2004·Application pending·0 cites
- 2559US2009253676A1Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of DiabetesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2657US2007112040A1Amino nicotinate derivatives as glucokinase (GLK) modulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2756US2009181962A1Substituted thiophene compoundsASTRAZENECA AB A SWEDEN CORP·Filed 2007·Application pending·0 cites
- 2854US8003676B21,3,4-oxadiazole derivatives as DGAT1 inhibitorsASTRAZENECA AB·Filed 2007·Granted Aug 23, 2011·0 cites·8 claims
- 2949US2011071144A1Quinazoline derivatives and pharmaceutical compositions containing themTHOMAS ANDREW PETER·Filed 2010·Application pending·0 cites
- 3049US2008280872A1Benzamide Derivatives and Their Use as Glucokinase Activating AgentsJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3149US2011152234A1Novel CompoundsFAULL ALAN·Filed 2010·Application pending·0 cites
- 3248US2009062351A1Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2004·Application pending·0 cites
- 3347US2010216791A1Pyridinylquinazolinamine derivatives and their use as b-raf inhibitorsASTRAZENECA·Filed 2007·Application pending·0 cites
- 3446US2007255062A1Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) ActivatorsJOHNSTONE CRAIG·Filed 2004·Application pending·0 cites
- 3545US2004214868A1Amino nicotinate derivatives as glucokinase (GLK) modulatorsFiled 2002·Application pending·0 cites
- 3645US2008280874A1Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and ObesityJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3745US2009018157A1Chemical compoundsJOHNSTONE CRAIG·Filed 2004·Application pending·0 cites
- 3843US2010137397A1Chemical CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3943US2011034432A1Benzamide derivatives and their use as glucokinase activating agentsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 4041US2007287693A1Benzamide Derivatives That Act Upon The Glucokinase EnzymeJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 4141US2008312207A1CompoundsJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 4239US2003087956A1Urea compounds as inhibitors for vla-4Filed 2001·Application pending·0 cites
- 4338US2009124682A1Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory ActivityBIRCH ALAN MARTIN·Filed 2006·Application pending·0 cites
- 4431US6441012B1Chemical compoundsASTRAZENECA AB·Filed 1999·Granted Aug 27, 2002·0 cites·8 claims
- 4530US6344570B1Substituted urea derivatives as cell adhesion inhibitorsASTRAZENECA UK LTD·Filed 1998·Granted Feb 5, 2002·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Craig Johnstone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →